English
日本語
signup
login
Repository
Search
Annotators
Editors
Evaluators
NEWS
Documentation
>
top
>
projects
>
hydroxychloroquine
> docs
hydroxychloroquine
Documents
(914)
JSON
TSV
source DB
source ID
text
size
updated at
# proj.
# Ann.
updated_at
PubMed
32474885
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. COVID-19 infection has a heterogenous disease course; it may be asymptomatic or causes only mild sy
1.7 KB
2020-06-04
4
6
2021-01-18
PubMed
32474476
Risk of using hydroxychloroquine as a treatment of COVID-19. The emerging COVID-19 pandemic poses a threat to the global health care system. Given the lack of antiviral therapies or vaccines for the d
1.04 KB
2020-06-04
16
2
2021-01-18
PubMed
32473812
Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence. Chloroquine and hydroxychloroquine are drugs that have shown in vitro activity on the replication
1.67 KB
2020-06-04
2
1
2021-01-18
PubMed
32473681
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. BACKGROUND: Data on patients with COVID-19 who have cancer are lacking. Here we characterise the outcomes of a cohort of pa
3.02 KB
2020-06-04
3
17
2021-01-18
PubMed
32473310
Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system. Coronavirus Disease 2019 (
1.62 KB
2020-06-04
2
0
2021-01-18
PubMed
32473020
Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial. Around the world, several dose regimens of hydroxychloroquine have been used for C
937 Bytes
2020-06-04
3
0
2021-01-18
PubMed
32471903
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. OBJECTIVES: COVID-19 out
1.94 KB
2020-06-04
5
1
2021-01-18
PubMed
32471876
Registries Offer Insights on COVID-19-Cancer Connection. Findings from CCC19 and TERAVOLT suggest that patients with cancer may be more likely to die from COVID-19 than people in the general populatio
356 Bytes
2020-06-04
22
2
2021-01-18
PubMed
32471001
COVID-19 in elderly kidney transplant recipients. The SARS-Cov-2 infection disease (COVID-19) pandemic has posed at risk the kidney transplant (KT) population, particularly the elderly recipients. Fro
1.3 KB
2020-06-04
3
2
2021-01-18
PubMed
32470568
Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review. BACKGROUND: Repurposing hydroxychloroquine (HCQ) and chloroquine (CQ) as antiviral agents
2.04 KB
2020-06-04
2
0
2021-01-18
Page 17